HomeCompareFMXVF vs MRK

FMXVF vs MRK: Dividend Comparison 2026

FMXVF yields 6022.28% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FMXVF wins by $380731087462511.81M in total portfolio value
10 years
FMXVF
FMXVF
● Live price
6022.28%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$380731087462511.88M
Annual income
$368,688,058,570,212,440,000.00
Full FMXVF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — FMXVF vs MRK

📍 FMXVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFMXVFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FMXVF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FMXVF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FMXVF
Annual income on $10K today (after 15% tax)
$511,894.01/yr
After 10yr DRIP, annual income (after tax)
$313,384,849,784,680,550,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, FMXVF beats the other by $313,384,849,784,680,550,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FMXVF + MRK for your $10,000?

FMXVF: 50%MRK: 50%
100% MRK50/50100% FMXVF
Portfolio after 10yr
$190365543731255.97M
Annual income
$184,344,029,285,106,220,000.00/yr
Blended yield
96.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FMXVF
No analyst data
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FMXVF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFMXVFMRK
Forward yield6022.28%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$380731087462511.88M$57.7K
Annual income after 10y$368,688,058,570,212,440,000.00$10,113.78
Total dividends collected$379920834048572.13M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FMXVF vs MRK ($10,000, DRIP)

YearFMXVF PortfolioFMXVF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$612,928$602,228.24$11,213$373.04+$601.7KFMXVF
2$35,153,282$34,497,448.66$12,667$512.06+$35.14MFMXVF
3$1,886,709,936$1,849,095,924.36$14,439$708.14+$1886.70MFMXVF
4$94,768,994,329$92,750,214,697.29$16,640$988.16+$94768.98MFMXVF
5$4,455,441,488,430$4,354,038,664,498.15$19,432$1,394.07+$4455441.47MFMXVF
6$196,075,254,024,580$191,307,931,631,960.38$23,057$1,992.90+$196075254.00MFMXVF
7$8,078,106,502,060,834$7,868,305,980,254,532.00$27,889$2,894.79+$8078106502.03MFMXVF
8$311,602,847,614,213,300$302,959,273,657,008,200.00$34,518$4,286.29+$311602847614.18MFMXVF
9$11,255,167,189,064,905,000$10,921,752,142,117,698,000.00$43,912$6,494.35+$11255167189064.86MFMXVF
10$380,731,087,462,511,900,000$368,688,058,570,212,440,000.00$57,714$10,113.78+$380731087462511.81MFMXVF

FMXVF vs MRK: Complete Analysis 2026

FMXVFStock

Amilot Capital Inc., a mineral resource company, acquires, explores for, develops, and exploits mineral properties in Canada and Colombia. It primarily explores for gold deposits. The company holds interest in the ANCAL property that includes 32 mining concessions, exploitation licenses, and applications covering an area of approximately 21,382 hectares situated in the Marmato/Caramanta districts in Colombia. It also holds interests in the NORTOL property, which consists of 29 mining concessions and applications covering an area of approximately 39,546 hectares located in Tolima district in Colombia; and the Papayo property that comprises approximately 400 meters of galleries covering an area of approximately 15,000 square meters located in the Tolima district in Colombia. The company was formerly known as Tolima Gold Inc. and changed its name to Amilot Capital Inc. in January 2019. The company is based in Toronto, Canada.

Full FMXVF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this FMXVF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FMXVF vs SCHDFMXVF vs JEPIFMXVF vs OFMXVF vs KOFMXVF vs MAINFMXVF vs JNJFMXVF vs ABBVFMXVF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.